Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong · Delayed Price · Currency is HKD 53.65
+1.35 (2.58%)
Oct 21, 2026, 2:55 PM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 29.25 billion as of October 20, 2026. It is the 4,430th most valuable company in the world and the 217th biggest in Hong Kong. Its market cap has decreased by 26.27% in one year.
Market Cap
29.25B
Enterprise Value
32.71B
Revenue
8.58B
Global Rank
Country Rank
#217 Hong Kong
PE Ratio
28.68
ChartMarket Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has increased from 26.66B to 29.25B, an increase of 9.73%. That is a compound annual growth rate of 1.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 29.25B | -5.65% |
| Dec 31, 2025 | 31.01B | 140.72% |
| Dec 31, 2024 | 12.88B | 70.50% |
| Dec 29, 2023 | 7.55B | 8.59% |
| Dec 30, 2022 | 6.96B | -41.95% |
| Dec 31, 2021 | 11.98B | -53.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RemeGen | 54.97B |
| Biocytogen Pharmaceuticals (Beijing) | 37.86B |
| 3SBio | 36.64B |
| Shanghai Junshi Biosciences | 31.67B |
| InnoCare Pharma | 26.42B |
| Keymed Biosciences | 25.51B |
| InSilico Medicine Cayman TopCo | 22.71B |
| Zai Lab | 21.20B |